
Organovo Holdings ONVO
Quartalsbericht 2025-Q4
hinzugefügt 11.02.2026
Organovo Holdings EV/EBITDA 2011-2026 | ONVO
EV/EBITDA Jährlich Organovo Holdings
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.992 | -1.32 | -3 | -2.62 | -5.9 | -5 | -10.4 | -18.7 | -1.37 K | -18.6 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 0.992 | -1.37 K | -144 |
EV/EBITDA anderer Aktien in der Diagnostik & Forschung
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 17.01 | -0.12 % | $ 179 M | ||
|
Agilent Technologies
A
|
27.4 | $ 118.05 | 0.44 % | $ 35.9 B | ||
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
-100 | $ 20.96 | 1.26 % | $ 1.12 B | ||
|
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | ||
|
Co-Diagnostics
CODX
|
3.62 | $ 1.61 | 1.26 % | $ 2.14 M | ||
|
Castle Biosciences
CSTL
|
-21.2 | $ 24.81 | 0.85 % | $ 689 M | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
22 | $ 183.48 | -1.03 % | $ 9.09 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 427.17 | -0.73 % | $ 12.3 B | ||
|
Myriad Genetics
MYGN
|
-17.2 | $ 4.01 | -20.18 % | $ 371 M | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | - | - | $ 19.8 B | ||
|
NeoGenomics
NEO
|
-33.5 | $ 8.89 | 0.28 % | $ 1.14 B | ||
|
National Research Corporation
NRC
|
21 | $ 17.96 | -4.16 % | $ 402 M | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 15.03 | 0.87 % | $ 454 M | ||
|
Natera
NTRA
|
-19.5 | $ 217.47 | 5.17 % | $ 21.4 B | ||
|
Koninklijke Philips N.V.
PHG
|
55.6 | $ 27.16 | 2.68 % | $ 20 B | ||
|
Guardant Health
GH
|
-28.8 | $ 92.19 | 2.98 % | $ 11.6 B | ||
|
Personalis
PSNL
|
-7.07 | $ 6.01 | 8.09 % | $ 356 M | ||
|
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 123.63 | 1.9 % | $ 10.2 B | ||
|
Illumina
ILMN
|
70.5 | $ 141.82 | 1.97 % | $ 22.5 B | ||
|
Soleno Therapeutics
SLNO
|
0.12 | $ 52.93 | 0.02 % | $ 2.69 B | ||
|
Senseonics Holdings
SENS
|
-13.8 | $ 5.38 | 7.6 % | $ 224 M | ||
|
Interpace Biosciences
IDXG
|
-6.02 | $ 2.05 | 2.09 % | $ 9.07 M | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Thermo Fisher Scientific
TMO
|
19.3 | $ 472.27 | 1.18 % | $ 178 B | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.22 | 1.6 % | $ 5.1 M | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 85.47 | -0.41 % | $ 5.77 B | ||
|
Trinity Biotech plc
TRIB
|
12.6 | $ 0.61 | 2.11 % | $ 61.9 M | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 257.56 | 0.16 % | $ 21.4 B | ||
|
Twist Bioscience Corporation
TWST
|
-23.6 | $ 59.55 | 5.03 % | $ 3.56 B | ||
|
Celcuity
CELC
|
-2.38 | $ 139.94 | -1.24 % | $ 6.54 B | ||
|
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
40.3 | $ 9.16 | -1.13 % | $ 1.99 B | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 189.52 | -0.69 % | $ 21 B | ||
|
Waters Corporation
WAT
|
24.6 | $ 348.15 | 1.58 % | $ 20.7 B |